Tobacco Product Establishment
Registration and Submission of Certain Health Information
Extension without change of a currently approved collection
No
Regular
08/12/2022
Requested
Previously Approved
36 Months From Approved
09/30/2022
3,258
3,858
962
830
0
21
The Federal Food, Drug, and Cosmetic
Act (FD&C Act), amended by the Tobacco Control Act of 2009,
grants FDA the authority to regulate the manufacture, marketing,
and distribution of tobacco products to protect the public health
generally and to reduce tobacco use by minors. Section 905 of the
FD&C Act requires the annual registration of any establishment
in any State engaged in the manufacture, preparation, compounding,
or processing of a tobacco product or tobacco products. Section 904
of the FD&C Act requires that each tobacco product manufacturer
or importer submit a listing of all ingredients and additives that
are added by the manufacturer to each tobacco product by brand and
by quantity in each brand and sub brand. Section 904 also requires
that a tobacco product manufacturer advise the FDA in writing prior
to adding any new tobacco additive or increasing in quantity an
existing tobacco additive. It also requires that a tobacco product
manufacturer advise the FDA in writing prior to eliminating or
decreasing an existing additive, or adding or increasing an
additive designated by the FDA as not a human or animal carcinogen,
or otherwise harmful to health under intended conditions of
use.
PL:
Pub.L. 111 - 111 31 Name of Law: Family Smoking Prevention and
Tobacco Control Act
US Code: 21
USC 905 Name of Law: FFDCA
US Code: 21
USC 904 Name of Law: FFDCA
We have adjusted our burden
estimate, which has resulted in an increase of 132 hours to the
currently approved burden. FDA now estimates the total burden for
this collection to be 962 hours. The Consolidated Appropriations
Act of 2022 (the Appropriations Act), enacted on March 15, 2022,
amended the definition of the term “tobacco product” in section
201(rr) of the FD&C Act to include products that contain
nicotine from any source. As a result, non-tobacco nicotine (NTN)
products that were not previously subject to the FD&C Act
(e.g., products containing synthetic nicotine) are now subject to
all of the tobacco product provisions in the FD&C Act beginning
on April 14, 2022. Based on this new authority the owners and
operators of establishments engaged in the manufacture,
preparation, compounding, or processing of tobacco products
containing non-tobacco nicotine (NTN) must register with the FDA
and list all these tobacco products that they manufacture, prepare,
compound, or process for commercial distribution. As such we have
revised the estimates in the burden chart to account for products
containing non-tobacco nicotine (NTN). We have therefore revised
the number of respondents and burden hours in this information
collection.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.